Able Partners — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Faeth Therapeuticsfaeththerapeutics.com inNASDAQ: FTHAug 2025

Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.

BiotechHealthtechAustin, US

Anand Parikh(Executive Officer, Director, Promoter)inOliver Maddocks(Executive Officer, Director)inChristopher W. Gerry(President and General Counsel)

BoardAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)

Co-investorsAtacama Ventures Cota Capital Future Ventures iSelect Fund S2G Investments AgFunder +7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.